Data Gathering for A10900
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorOptos, PLC
About this trial
The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
Eligibility criteria
Qualifiers
None
Disqualifiers
Participants 22 years of age or older on the date of informed consent
Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
BCVA 20/400 or better in the study eye
Participants presenting at the site with retinal disease
Trial design
Treatments tested in this trial
- OCT
Treatment groups
180 Participants
are divided into 4 treatment groupsLocations
4Ketchum Health92807, AnaheimCalifornia, United States
Eye Disease Consultants, LLC06107, West HartfordConnecticut, United States
Eye Care and Laser Surgery of Newton Wellselley02481, Wellesley HillsMassachusetts, United States
Charles Retina Institute38138, GermantownTennessee, United States
Sponsors and collaborators
Optos, PLC
Lead sponsor
Source ClinicalTrials.gov